In HER2+ breast cancer, FCGRIA and FCGR2A were expressed on monocytes and macrophages (Fig. 1C), whereas in TNBC, FCGRIA and FCGR2A were expressed on monocytes, macrophages, and DCs (Fig. 1D). The gene discussed is FCGR2A; the disease is breast carcinoma.